Indoco Remedies Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Indoco Remedies Ltd. from all sources in a single place.

Indoco Remedies Ltd.

27 May 2025, 03:45PM

245.60

-1.01%

Company Update

Indoco Remedies Ltd - 532612 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Enclosed the Annual Secretarial Compliance Report dated 22-05-2025 for the FY 2024-25 issued by our secretarial auditor CS Ajit Sathe, Proprietor of M/s. A Y Sathe & Co, Company Secretaries.

pdf

Indoco Remedies Ltd.

26 May 2025

245.60

-1.01%

Earnings Call

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Earnings Conference Call on Audited Standalone and Consolidated Financial Results for the quarter and year ended 31-03-2025

pdf

Indoco Remedies Ltd.

23 May 2025

245.60

-1.01%

Company Update

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication of Audited Standalone & Consolidated Financial Results for the quarter and year ended 31-03-2025

pdf

Indoco Remedies Ltd.

23 May 2025

245.60

-1.01%

What drove Indoco Remedies share price 6% higher today? Top details inside

Business Standard

Indoco Remedies' share price rose after the company received final USFDA approval for its ANDA to market Allopurinol tablets USP, 200 mg - a generic version of Zyloprim 200 mg by Casper Pharma LLC.

Indoco Remedies Ltd. is trading below its 100 day SMA of 256.3

Indoco Remedies Ltd.

23 May 2025

245.60

-1.01%

Company Update

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we wish to inform you that the management of the Company will be meeting analysts/investors on 29-05-2025 at the B&K Securities 15th Annual Investor Conference - Trinity India 2025

pdf

Indoco Remedies Ltd.

23 May 2025

245.60

-1.01%

Company Update

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Indoco Remedies receives final approval from the USFDA for Allopurinol Tablets USP 200mg

pdf

Indoco Remedies Ltd.

22 May 2025

245.60

-1.01%

Earnings Call

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Audio recording of Earnings Conference Call on Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended 31st March, 2025

pdf

Indoco Remedies Ltd.

22 May 2025

245.60

-1.01%

to see Rapid results content

Indoco Remedies Ltd.

22 May 2025

245.60

-1.01%

Company Update

Indoco Remedies Ltd - 532612 - Appointment Of Secretarial Auditor And Internal Auditor Of The Company

BSE India

Re-appointment of A.Y.Sathe & Co. as the Secretarial Auditor of the Company and Suresh Surana & Associates LLP as Internal Auditors of the Company

pdf

Indoco Remedies Ltd.

22 May 2025

245.60

-1.01%

Company Update

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

Re-appointment of Dr. Vasudha Kamat and Mr. Abhijit Gore as an Independent Directors of the Company for second term of five years subject to the approval of the shareholders.

pdf